Evidence map›Paper›PMID 28630810›Full record

ArticleMass spectrometry (Tokyo, Japan)2017

Negative Ion Mode Electrospray Tandem Mass Spectrometry of Hydroxy-Terminated Polydimethylsiloxanes Formed upon

Thierry Fouquet, Laurence Charles, Hiroaki Sato

Open access · diamondAbstract read
In one paragraph

Article in Mass spectrometry (Tokyo, Japan), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Thierry FouquetNational Institute of Advanced Industrial Science and Technology (AIST), Research Institute for Sustainable Chemistry.
Laurence CharlesAix Marseille University, CNRS, ICR, Institut de Chimie Radicalaire.
Hiroaki SatoNational Institute of Advanced Industrial Science and Technology (AIST), Research Institute for Sustainable Chemistry.
National Institute of Advanced Industrial Science and Technology · JPInstitut de Chimie Radicalaire · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ethoxy-, methoxy- and hydroxy-terminated polydimethylsiloxanes (PDMS) are formed as the result of the methanolysis of diethoxy-ended PDMS during its infusion in electrospray ionization. The negative ion mode permits only hydroxy-ended products to be detected, and isomeric interference is avoided in single stage and tandem mass spectrometry. The routes for the fragmentation of (ethyl, hydroxy)-, (methyl, hydroxy)- and (hydro, hydroxy)-ended PDMS upon collision activated dissociation (CAD) were explored in the negative ion mode using either formate or acetate anion adduction. Symmetrical (hydro, hydroxy)-ended PDMS decomposed to product ions carrying one of the hydroxy terminations through the abstraction of an acidic hydrogen and depolymerization (expulsion of cyclic neutral species) regardless of the adducted anion. Asymmetric (ethyl, hydroxy)-ended (resp. (methyl, hydroxy)-ended) PDMS yielded both ethoxy-ended (resp. methoxy-ended) fragment ions through the abstraction of the only acidic hydrogens and linear product ions carrying both terminations still interacted with the anion. The production of information-rich ethoxy-ended (resp. methoxy-ended) fragment ions was limited by formate but favored when acetate (higher proton affinity) was used in a CAD fingerprint complementary to the positive ion mode.

Indexed as

collision activated dissociationelectrospray ionizationnegative ion modepolydimethylsiloxanetandem mass spectrometry

Identifiers

PMID28630810
PMCPMC5469726
OpenAlexW2625782876

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.